air (artificial implant to restore the medial meniscus function)2 clinical investigation

Conditions: Knee Injuries and Disorders

Summary: the air2 study is a multi-center, prospective, interventional clinical trial with the objective to evaluate the safety and performance of the trammpolin® medial meniscus prosthesis.

the trammpolin® meniscus prosthesis is intended to replace the native medial meniscus to provide pain relief in the medial compartment of the knee joint, when this is caused by medial partial meniscectomy. patients who meet the inclusion/exclusion criteria and who are implanted with the trammpolin® medial meniscus prosthesis will be followed for 2 years. the patient reported outcome measures for knee pain and function, and knee clinical condition by mri and x-ray is assessed post-operative compared to pre-operative.

Eligibility criteria:
inclusion criteria: 1. has medial compartment knee pain and had a medial partial or total meniscectomy \> 6 months ago. the lack of meniscus tissue is confirmed by patient history and mri 2. has a koos pain of ≤ 75 (100 being no pain and the highest attainable score) 3. is between age 18 and 70 years (inclusive) at the time of screening 4. has neutral alignment ± 5° of the mechanical axis, i.e., the angle formed by a line drawn from the center of the femoral head to the medial tibial spine and a line drawn from the medial tibial spine to the center of the ankle joint, as confirmed by x-ray 5. is willing to be implanted with the trammpolin® medial meniscus prosthesis 6. is willing and able to comply to the clinical investigation required follow up visits, questionnaires, x-rays and mri's 7. is able and willing to understand and sign the clinical investigation informed consent form 8. is able to read and understand the national language of the country in which the relevant clinical site is located exclusion criteria: 1. has a symptomatic knee because of a tear that could potentially be addressed by a repeat partial meniscectomy 2. has evidence of a modified outerbridge grade iv cartilage loss on the medial tibial plateau or femoral condyle that potentially could contact a trammpolin® medial meniscus prosthesis 3. has lateral compartment pain and grade iii or grade iv modified outerbridge cartilage score in the lateral compartment 4. has a varus or valgus knee deformity of \> 5° requiring a tibial or femoral osteotomy 5. has a varus alignment that is not passively correctable 6. has a laxity level of more than grade ii (ikdc), primary or secondary to an injury of the anterior cruciate ligament (acl) and/or posterior cruciate ligament (pcl) and/or lateral collateral ligament (lcl) and/or medial collateral ligament (mcl) 7. has significant trochlear dysplasia, patellar instability or symptomatic patellar misalignment 8. has patellar compartment pain and grade iii or grade iv modified outerbridge cartilage score in the patellar compartment. 9. compared to a normal knee, has obvious radiological evidence of medial femoral squaring, anatomical variance in the medial tibial plateau, or irregularly shaped cartilage surface 10. had an acl reconstruction performed \< 9 months prior to surgery 11. has a bmi \> 30 at the time of screening 12. has a knee flexion contracture \> 10° 13. has a knee flexion \< 90° 14. had a previous high tibial osteotomy (hto) \< 1 year ago 15. has insufficiency fractures or avascular necrosis of the medial compartment 16. has an active infection or tumor (local or systemic) 17. has any type of knee joint inflammatory disease including sjogren's syndrome 18. has neuropathic knee osteoarthropathy, also known as charcot joint 19. has any medical condition that does not allow possible arthroscopy of the knee 20. has neurological deficit (sensory, motor, or reflex) 21. is currently involved in another investigation of the lower extremity 22. anticipates having another lower extremity surgery during the clinical investigation period 23. has received any corticosteroid knee injections ≤ 3 months prior to surgery 24. has proven osteoporosis 25. is on immunostimulating or immunosuppressing agents 26. has ipsilateral or contralateral lower limb joint conditions that may affect ambulation or koos (e.g. have a leg length discrepancy \> 2.5 cm \[1 inch\], causing a noticeable limp) 27. is a female who is lactating, expecting, or is intending to become pregnant during the clinical investigation period 28. is mentally incapacitated (incapable of appraising or controlling conduct) or have mental disability (e.g., dementia or alzheimer's) 29. has a condition or be in a situation that, in the investigator's opinion, may confound the clinical investigation results, may risk the safety of the patient, or may interfere significantly with the subject's participation in the clinical investigation

Keywords: medial meniscus prosthesis symptomatic uni-compartmental pain